Canada: Food, Drugs, Healthcare, Life Sciences

Santé Canada propose un projet pilote visant à prioriser certaines présentations de médicaments génériques fabriqués au Canada dans la file d'attente d'examen réglementaire. Cette initiative cherche à déterminer si un accès accéléré à l'examen peut améliorer la prévisibilité des délais et contribuer à prévenir les pénuries de médicaments au pays.

The Omnipod insulin pump system, a widely-used device for diabetes management, faces serious medical device recalls due to manufacturing defects that can compromise insulin delivery. These defects may lead to severe health complications including hyperglycemia and diabetic ketoacidosis, prompting legal investigations into potential claims against manufacturer Insulet Corporation. Canadian users of the recalled devices who have experienced serious health issues are urged to seek legal consultation regarding

On June 17, 2026, Health Canada published the Regulations Amending Certain Regulations Made Under the Food and Drugs Act (Shortages and Discontinuation of Sale of Drugs and Medical Devices) (the “Amending Regulations”), introducing amendments to the Food and Drug Regulations (“FDR”) and the Medical Devices Regulations (“MDR”).